Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06213519
What this trial is testing

HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Peritoneal MetastasesGastric Cancer
Sichuan University 69
Testing effectiveness (Phase 2)Study completedNCT01040000
What this trial is testing

QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer

Who this might be right for
Metastatic Pancreatic CancerMetastatic Colorectal Cancer
Precision Biologics, Inc 94
Testing effectiveness (Phase 2)UnknownNCT03400592
What this trial is testing

Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Peking University 55
Early research (Phase 1)Active Not RecruitingNCT06532344
What this trial is testing

An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Ono Pharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)WithdrawnNCT00002664
What this trial is testing

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
James Ahlgren
Not applicableStudy completedNCT05247164
What this trial is testing

EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
IRCCS San Raffaele 23
Not applicableUnknownNCT02184663
What this trial is testing

Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Unresectable Locally Advanced CancerMetastatic Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 313
Not applicableStudy completedNCT03528863
What this trial is testing

Web-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their Caregivers

Who this might be right for
CaregiverMetastatic Gastrointestinal Carcinoma
University of California, San Francisco 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03816163
What this trial is testing

Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 393
Testing effectiveness (Phase 2)WithdrawnNCT01953406
What this trial is testing

The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLung Metastasis
Seoul National University Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06778031
What this trial is testing

A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 54
Early research (Phase 1)Study completedNCT01640665
What this trial is testing

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Who this might be right for
Metastatic Breast CancerGastrointestinal Tumors
Yale University 24
Testing effectiveness (Phase 2)UnknownNCT05143099
What this trial is testing

Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC

Who this might be right for
Colorectal Neoplasms
Shanghai Zhongshan Hospital 35
Post-approval studies (Phase 4)UnknownNCT02631499
What this trial is testing

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Who this might be right for
Carcinoma, HepatocellularNeoplastic Cells, Circulating
Fudan University 256
Testing effectiveness (Phase 2)Ended earlyNCT05039944
What this trial is testing

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Who this might be right for
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 7
Not applicableEnded earlyNCT03949907
What this trial is testing

Early IntraVenous Administration of Nutritional Support

Who this might be right for
Cancer of StomachGastroEsophageal Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 34
Not applicableActive Not RecruitingNCT07448493
What this trial is testing

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerBrain Metastases
Blokhin's Russian Cancer Research Center 230
Large-scale testing (Phase 3)Active Not RecruitingNCT04607421
What this trial is testing

Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Pfizer 841
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Next Page